JAVELIN head and neck 100: A phase 3 trial of avelumab in combination with chemoradiotherapy (CRT) vs CRT for 1st-line treatment of locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) Meeting Abstract


Authors: Lee, N. Y.; Ferris, R. L.; Beck, J. T.; Harrington, K.; Haddad, R. I.; Bourhis, J.; Tahara, M.; Geraldes, M.; Nuyten, D. S. A.; Goldberg, Z.; Cohen, E. E. W.
Abstract Title: JAVELIN head and neck 100: A phase 3 trial of avelumab in combination with chemoradiotherapy (CRT) vs CRT for 1st-line treatment of locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Start Page: 338s
Language: English
ACCESSION: WOS:000411931705089
DOI: 10.1200/JCO.2017.35.15_suppl.TPS6093
PROVIDER: wos
Notes: Meeting Abstract: TPS6093 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nancy Y. Lee
    871 Lee